DK0765320T3 - Benzimidazolonderivater med central dopaminerg aktivitet - Google Patents
Benzimidazolonderivater med central dopaminerg aktivitetInfo
- Publication number
- DK0765320T3 DK0765320T3 DK95914492T DK95914492T DK0765320T3 DK 0765320 T3 DK0765320 T3 DK 0765320T3 DK 95914492 T DK95914492 T DK 95914492T DK 95914492 T DK95914492 T DK 95914492T DK 0765320 T3 DK0765320 T3 DK 0765320T3
- Authority
- DK
- Denmark
- Prior art keywords
- dopaminergic activity
- central dopaminergic
- benzimidazolone derivatives
- derivatives
- benzimidazolone
- Prior art date
Links
- 150000008641 benzimidazolones Chemical class 0.000 title abstract 2
- 230000003291 dopaminomimetic effect Effects 0.000 title abstract 2
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Addiction (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25970794A | 1994-06-14 | 1994-06-14 | |
| PCT/IB1995/000285 WO1995034555A1 (en) | 1994-06-14 | 1995-04-24 | Benzimidazolone derivatives with central dopaminergic activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0765320T3 true DK0765320T3 (da) | 2001-11-26 |
Family
ID=22986031
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK95914492T DK0765320T3 (da) | 1994-06-14 | 1995-04-24 | Benzimidazolonderivater med central dopaminerg aktivitet |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0765320B1 (da) |
| JP (1) | JP2860604B2 (da) |
| AT (1) | ATE206708T1 (da) |
| CA (1) | CA2192975C (da) |
| DE (1) | DE69523155T2 (da) |
| DK (1) | DK0765320T3 (da) |
| ES (1) | ES2163506T3 (da) |
| FI (1) | FI113767B (da) |
| MX (1) | MX9606450A (da) |
| PT (1) | PT765320E (da) |
| WO (1) | WO1995034555A1 (da) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0953567A3 (en) * | 1998-04-29 | 2003-04-02 | Pfizer Products Inc. | Bicyclic substituted piperazine-, piperidine- and tetrahydropyridine derivatives, their preparation and their use as agents with central dopaminergic (dopamine D4 receptor) activity |
| HN1999000146A (es) * | 1998-09-21 | 2000-11-11 | Pfizer Prod Inc | Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas. |
| EP1177792A3 (en) * | 2000-07-27 | 2002-10-23 | Pfizer Products Inc. | Dopamine D4 Ligands for the treatment of novelty-seeking disorders |
| AU2001293804A1 (en) * | 2000-09-19 | 2002-04-02 | Boehringer Ingelheim Pharma Kg | New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors |
| US6586435B2 (en) | 2000-09-19 | 2003-07-01 | Boehringer Ingelheim Pharma Kg | Benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors |
| US7183410B2 (en) | 2001-08-02 | 2007-02-27 | Bidachem S.P.A. | Stable polymorph of flibanserin |
| UA78974C2 (en) | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
| US10675280B2 (en) | 2001-10-20 | 2020-06-09 | Sprout Pharmaceuticals, Inc. | Treating sexual desire disorders with flibanserin |
| JP2004123562A (ja) * | 2002-09-30 | 2004-04-22 | Japan Science & Technology Corp | 神経細胞死抑制作用を有する化合物を用いた医薬 |
| US7459469B2 (en) | 2004-11-10 | 2008-12-02 | Targacept, Inc. | Hydroxybenzoate salts of metanicotine compounds |
| US8227476B2 (en) | 2005-08-03 | 2012-07-24 | Sprout Pharmaceuticals, Inc. | Use of flibanserin in the treatment of obesity |
| CA2626134C (en) | 2005-10-29 | 2013-12-24 | Boehringer Ingelheim International Gmbh | Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders |
| EP2133337A1 (en) | 2006-05-09 | 2009-12-16 | AstraZeneca AB | Salt forms of (2S)-(4E)-N-Methyl-5-[(5-Isopropoxy)pyridin-3-yl]-4-penten-2-amine |
| TWI389889B (zh) | 2006-05-09 | 2013-03-21 | Targacept Inc | （２ｓ）-（４ｅ）-ｎ-甲基-５-〔３-（５-異丙氧基吡啶）基〕-４-戊烯-２-胺之新穎多晶型 |
| US20090312242A1 (en) | 2006-06-30 | 2009-12-17 | Ramiro Castro | Flibanserin for the treatment of urinary incontinence and related diseases |
| CA2660476C (en) | 2006-08-14 | 2015-11-17 | Boehringer Ingelheim International Gmbh | Formulations of flibanserin and method for manufacturing the same |
| EP2056797A2 (en) | 2006-08-25 | 2009-05-13 | Boehringer Ingelheim International GmbH | Controlled release system and method for manufacturing the same |
| PE20091188A1 (es) | 2007-09-12 | 2009-08-31 | Boehringer Ingelheim Int | Compuesto 1-[2-(4-(3-trifluorometil-fenil)piperazin-1-il)etil]-2,3-dihidro-1h-benzimidazol-2-ona (flibanserina), sus sales de adicion y composiciones farmaceuticas que los contienen |
| AU2011256866B2 (en) | 2010-05-20 | 2014-05-22 | Astrazeneca Ab | New process for the preparation of aryl substituted olefinic amines |
| JP2018112616A (ja) | 2017-01-10 | 2018-07-19 | 富士フイルム株式会社 | 積層体、積層体の製造方法、および車両用ルームミラー |
| MX2022013843A (es) * | 2020-05-06 | 2022-11-30 | Merck Sharp & Dohme Llc | Inhibidores de il4i1 y metodos de uso. |
| CA3211341A1 (en) * | 2021-03-19 | 2022-09-22 | Centre National De La Recherche Scientifique | Applications of biased ligands of the serotonin 5-ht7 receptor for the treatment of pain, multiple sclerosis and the control of thermoregulation |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1251144B (it) * | 1991-07-30 | 1995-05-04 | Boehringer Ingelheim Italia | Derivati del benzimidazolone |
-
1995
- 1995-04-24 DE DE69523155T patent/DE69523155T2/de not_active Expired - Fee Related
- 1995-04-24 PT PT95914492T patent/PT765320E/pt unknown
- 1995-04-24 JP JP8501862A patent/JP2860604B2/ja not_active Expired - Fee Related
- 1995-04-24 WO PCT/IB1995/000285 patent/WO1995034555A1/en not_active Ceased
- 1995-04-24 DK DK95914492T patent/DK0765320T3/da active
- 1995-04-24 AT AT95914492T patent/ATE206708T1/de not_active IP Right Cessation
- 1995-04-24 ES ES95914492T patent/ES2163506T3/es not_active Expired - Lifetime
- 1995-04-24 MX MX9606450A patent/MX9606450A/es not_active IP Right Cessation
- 1995-04-24 CA CA002192975A patent/CA2192975C/en not_active Expired - Fee Related
- 1995-04-24 EP EP95914492A patent/EP0765320B1/en not_active Expired - Lifetime
-
1996
- 1996-12-13 FI FI965021A patent/FI113767B/fi active
Also Published As
| Publication number | Publication date |
|---|---|
| JPH09506637A (ja) | 1997-06-30 |
| FI965021L (fi) | 1996-12-13 |
| FI965021A0 (fi) | 1996-12-13 |
| ES2163506T3 (es) | 2002-02-01 |
| EP0765320B1 (en) | 2001-10-10 |
| FI113767B (fi) | 2004-06-15 |
| ATE206708T1 (de) | 2001-10-15 |
| CA2192975C (en) | 1999-09-21 |
| CA2192975A1 (en) | 1995-12-21 |
| WO1995034555A1 (en) | 1995-12-21 |
| JP2860604B2 (ja) | 1999-02-24 |
| MX9606450A (es) | 1997-03-29 |
| DE69523155D1 (de) | 2001-11-15 |
| DE69523155T2 (de) | 2002-02-07 |
| PT765320E (pt) | 2002-02-28 |
| EP0765320A1 (en) | 1997-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0765320T3 (da) | Benzimidazolonderivater med central dopaminerg aktivitet | |
| ATE177099T1 (de) | Diazabicyclische neurokinin antagonisten | |
| DK0804252T3 (da) | Monoamin-, diamid-, thiol-holdige metalchelateringsmidler | |
| MX9707980A (es) | Derivados de 4-aminoquinazolina, composiciones que los contienen, y uso de los mismos. | |
| SE9604786D0 (sv) | New compounds | |
| MY107157A (en) | Quinuclidine derivatives. | |
| FI970469A0 (fi) | Bentsimidatsolijohdannaisia, joilla on dopaminerginen aktiivisuus | |
| ES2181853T3 (es) | Tratamiento del tinnitus empleando agentes neuroprotectores. | |
| ATE233274T1 (de) | Oxyiminopregnancarbolactone | |
| TR199802060T2 (xx) | Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�. | |
| EA200000204A1 (ru) | Производные пирролопирролона в качестве ингибиторов эластазы нейтрофилов | |
| AP9701075A0 (en) | Spirocyclic dopamine receptor subtype ligands. | |
| NO176097C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte cykloheksener | |
| DE69030665D1 (de) | (1,2n) und (3,2n)-karbozyklische-2-amino-tetralinderivate | |
| NO20042729L (no) | Heksasykliske forbindelser | |
| BG105549A (en) | Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system | |
| ES2181387T3 (es) | Derivados de azetidinocarboxamida para el tratamiento de trastornos del sistema nervioso central. | |
| NO970498L (no) | Benzimidazolderivater med dopaminergisk aktivitet | |
| MX9704299A (es) | Derivados de bencimidazol. | |
| ECSP951500A (es) | Derivados de bencimidazol |